The exercise period for warrants series TO 13 ("TO 13") in Alligator Bioscience AB ("Alligator Bioscience" or the "Company") ended on 15 September 2025. The preliminary outcome indicates that a total ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback